These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Long-term survival (5-20 years) after pancreatectomy for pancreatic ductal adenocarcinoma: a series of 30 patients collected from 3 institutions. Adham M, Jaeck D, Le Borgne J, Oussoultzouglou E, Chenard-Neu MP, Mosnier JF, Scoazec JY, Mornex F, Partensky C. Pancreas; 2008 Nov; 37(4):352-7. PubMed ID: 18665012 [Abstract] [Full Text] [Related]
9. Evaluation of surgical resection for pancreatic carcinoma at a Japanese single cancer institute. Nanashima A, Tobinaga S, Abo T, Hatano K, Takeshita H, Nonaka T, Hidaka S, Tanaka K, Kunizaki M, Sawai T, Yasutake T, Nagayasu T. Hepatogastroenterology; 2012 May; 59(115):911-5. PubMed ID: 22469741 [Abstract] [Full Text] [Related]
10. Surgical outcome of intraductal papillary mucinous neoplasms of the pancreas. Nakagohri T, Kinoshita T, Konishi M, Takahashi S, Gotohda N. Ann Surg Oncol; 2007 Nov; 14(11):3174-80. PubMed ID: 17694416 [Abstract] [Full Text] [Related]
11. Clinical results of extended lymphadenectomy and intraoperative radiotherapy for pancreatic adenocarcinoma. Nakagohri T, Kinoshita T, Konishi M, Takahashi S, Tanizawa Y. Hepatogastroenterology; 2007 Mar; 54(74):564-9. PubMed ID: 17523323 [Abstract] [Full Text] [Related]
13. Intraductal papillary mucinous neoplasms of the pancreas: effect of invasion and pancreatic margin status on recurrence and survival. Raut CP, Cleary KR, Staerkel GA, Abbruzzese JL, Wolff RA, Lee JH, Vauthey JN, Lee JE, Pisters PW, Evans DB. Ann Surg Oncol; 2006 Apr; 13(4):582-94. PubMed ID: 16523362 [Abstract] [Full Text] [Related]
15. Carcinoma of the pancreas: resection outcome at the University Hospital Kuala Lumpur. Shahrudin MD. Int Surg; 1997 Apr; 82(3):269-74. PubMed ID: 9372373 [Abstract] [Full Text] [Related]
16. Treatment strategy for intraductal papillary mucinous neoplasm of the pancreas based on malignant predictive factors. Hirono S, Tani M, Kawai M, Ina S, Nishioka R, Miyazawa M, Fujita Y, Uchiyama K, Yamaue H. Arch Surg; 2009 Apr; 144(4):345-9; discussion 349-50. PubMed ID: 19380648 [Abstract] [Full Text] [Related]
17. Minimally invasive intraductal papillary-mucinous carcinoma of the pancreas: clinicopathologic study of 104 intraductal papillary-mucinous neoplasms. Nara S, Shimada K, Kosuge T, Kanai Y, Hiraoka N. Am J Surg Pathol; 2008 Feb; 32(2):243-55. PubMed ID: 18223327 [Abstract] [Full Text] [Related]
18. Clinical significance of frozen section analysis during resection of intraductal papillary mucinous neoplasm: should a positive pancreatic margin for adenoma or borderline lesion be resected additionally? Nara S, Shimada K, Sakamoto Y, Esaki M, Kosuge T, Hiraoka N. J Am Coll Surg; 2009 Nov; 209(5):614-21. PubMed ID: 19854402 [Abstract] [Full Text] [Related]
19. Role of intraoperative cytology combined with histology in detecting continuous and skip type intraductal cancer existence for intraductal papillary mucinous carcinoma of the pancreas. Eguchi H, Ishikawa O, Ohigashi H, Sasaki Y, Yamada T, Nakaizumi A, Uehara H, Takenaka A, Kasugai T, Imaoka S. Cancer; 2006 Dec 01; 107(11):2567-75. PubMed ID: 17054109 [Abstract] [Full Text] [Related]
20. Survival after resection of pancreatic adenocarcinoma: results from a single institution over three decades. Winter JM, Brennan MF, Tang LH, D'Angelica MI, Dematteo RP, Fong Y, Klimstra DS, Jarnagin WR, Allen PJ. Ann Surg Oncol; 2012 Jan 01; 19(1):169-75. PubMed ID: 21761104 [Abstract] [Full Text] [Related] Page: [Next] [New Search]